Top Health Tech Companies in Belfast (27)
Biotechnology is rewriting life as we know it, from the medicines we take, to the crops we grow, and the household goods that we rely on every day. But moving at the new speed of science requires better technology. Benchling’s mission is to unlock the power of biotechnology. The world’s most innovative biotech companies use Benchling’s R&D Cloud to power the...
Benchling's Top Stability & Growth Strengths
Strong Market Position & Advantage: Adoption spans 1,300+ biotechnology organizations with usage reported across more than half of the top 50 biopharma companies, signaling durable positioning in life‑sciences R&D software. Multiple sources characterize the platform as a leading life‑sciences R&D cloud used by both startups and major enterprises.
Product Line Growth: The company continues to launch and expand major offerings, including Benchling AI, antibody‑discovery capabilities, automation/analysis tools, and extensions into new scientific workflows such as small‑molecule chemistry. Acquisitions like PipeBio further broaden capability depth in biologics and related R&D domains.
Innovation-Driven Growth: AI is a clear growth vector, with reports that 500 biotech companies used Benchling AI in its first year and the product subsequently reached general availability. Team acquisitions (e.g., ReSync Bio and Sphinx Bio) and partnerships (e.g., with Anthropic) underscore a deliberate push to embed advanced models into scientific workflows.
Welcome! We are Northern Ireland’s Premier Private Healthcare Group. Our mission is to become a world-class provider of healthcare solutions by putting our patients to the forefront of everything we do. Our aim is to make the Kingsbridge Healthcare Group the preferred choice for both patients and healthcare professionals. Because Life Matters. Companies within the Kingsbridge Healthcare Group include: Kingsbridge...
System C Healthcare is a British health and social care technology company founded in 1983. It develops and deploys IT products and services for the NHS, social service authorities and social care providers. Through its Liquidlogic subsidiary, the company supplies social care and education management solutions that facilitate collaboration across health and care services. Its mission is to deliver technology...
Lucas Love Healthcare is a Northern Ireland nursing and domiciliary care agency that provides permanent, temporary, and contract recruitment of healthcare professionals. It supplies staff to care homes, hospitals, supported-living facilities, hospices, homecare providers, charities, and other health and social care settings. The company recruits nurses, care assistants, support workers, managers, chefs, kitchen assistants, domestic assistants, and administrators, with 24-hour...
Affidea is a pan-European diagnostic imaging and community-based polyclinic and specialist healthcare services provider, operating in Greece since 2005 to offer high-quality, integrated primary health services.
Lantum is a workforce management platform that makes it easier for healthcare providers to mobilise their workforce, and for clinicians to work more flexibly. Our Connected Scheduling platform gives you a staff bank, rota tool and a clinician network all in one place to improve fill rates, cut admin time, and reduce costs. We started life as Network Locum in...
AesthetiDocs combines Online Bookings & Documentation providing everything you need to run your whole clinic. Take your Aesthetic Clinic to the next level with AesthetiDocs bespoke booking and documentation application. Bookings, reminders, consent, documentation, prescriptions, aftercare photographs and payments can be managed by yourself or your clinic staff depending on your needs. A simple way to ensure you’re doing everything correctly to run...
Data Mastery is a data consultancy based in the Belfast and Dublin, helping organisations transform how they collect, model, and leverage data. We specialise in designing and delivering modern analytics solutions built on Azure, Microsoft Fabric and Power BI, enabling business users to make confident, data-informed decisions. Our approach is deeply consultative: we embed ourselves within client teams to understand business...
10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock. We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of...
IDEXX's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show double‑digit top‑line increases in 2025 and early 2026, with Q1 and Q2 2026 up 14% and 10% reported, respectively, and full‑year 2026 revenue guidance raised. Growth is broad‑based across Companion Animal Group diagnostics, Water, and LPD.
Profitability: Margin expansion is attributed to recurring diagnostics volume, pricing, and productivity, translating into higher EPS and operating leverage. Guidance and quarterly updates highlight continued earnings growth if these drivers are maintained.
Strong Market Position & Advantage: The company is widely regarded as the category leader in companion‑animal diagnostics, reinforced by an integrated ecosystem of instruments, consumables, labs, imaging, and software. Independent analyses consistently place it at or near the top across key diagnostics segments, supporting durable advantage.
We are a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, extraordinary talent and innovation, we ‘create better together’ by partnering with healthcare professionals. Our extensive range of products, services and integrated technologies fuel active lifestyles.
Enovis's Top Stability & Growth Strengths
Strong Revenue Growth: Full-year 2025 revenue reached about $2.2–$2.248B, described as up year over year with organic growth also cited, and 2026 guidance indicates continued expansion. Multi-year net sales progression from 2023 to 2025 is presented as consistently upward, with Reconstructive repeatedly cited as the primary growth engine.
Innovation-Driven Growth: The company is characterized as innovation-driven, highlighting investments such as the ARVIS Gen 2 augmented reality system and a steady cadence of new product launches across reconstructive and prevention/recovery offerings. Digital enablement and technology differentiation are framed as key enablers of share gains, especially in faster-growing niches like extremities/shoulder.
Strong Market Position & Advantage: Category leadership is asserted in bracing and rehab through legacy DJO brands (DonJoy, Aircast, Chattanooga), and the LimaCorporate acquisition is described as elevating the company into a top-tier position in extremities. The portfolio is positioned as strong in select segments even if not dominant across the entire orthopedic implant market.
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and...
Sanofi's Top Stability & Growth Strengths
Strong Revenue Growth: Sales growth is described as strong, with 2025 net sales up at constant exchange rates and Q4 showing further acceleration, indicating momentum into 2026.
Profitability: Earnings expansion is described as outpacing sales growth in 2025, and 2026 guidance indicates continued profitable expansion with EPS growing slightly faster than sales.
Product Line Growth: Newer launches are scaling rapidly, with notable growth in recent pharma launches and contributions from products beyond the flagship franchise, helping broaden growth drivers.
At Elanco, we work to improve the health of animals through innovative products and services for pets and farm animals around the world. As a global animal health company, we provide solutions that empower our customers to advance a vision of Food and Companionship Enriching Life. Since 1954, Elanco has committed to empowering veterinarians, farmers, and all those who care...
Elanco's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is growing year over year with acceleration in the latest quarter, and guidance indicates continued organic expansion into 2026.
Innovation-Driven Growth: Innovation revenue surpassed targets and management raised the next-year goal, supported by new launches such as Befrena, Credelio Quattro, Zenrelia, AdTab, and Experior.
Future-Ready Strategy: A multi‑year plan calls for ongoing organic growth and improving earnings metrics, underpinned by a late‑stage pipeline expected to deliver multiple potential blockbusters through 2026–2031.
Healthcare is complex enough, finding the knowledge you need shouldn’t be. Eolas Medical is a knowledge management platform for clinicians, enabling instant access to information at the point of care. The platform is used by NHS Trusts, clinical teams, and individuals to support the delivery of patient care by consolidating and organising medical knowledge from trusted sources into a simple, easy-to-use...
ResMed provides medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
ResMed's Top Stability & Growth Strengths
Strong Market Position & Advantage: Industry and company materials indicate ResMed is the leading player in global sleep‑apnea devices and masks, supported by scale and a large connected ecosystem (AirView/myAir). Philips’ U.S. consent decree and extended remediation have provided a multi‑year window that reinforced ResMed’s relative momentum.
Strong Revenue Growth: Recent quarters show continued year‑over‑year revenue growth with margin expansion, driven by device demand and recurring masks/accessories. Management commentary and investor materials point to sustained momentum through FY2026 to date.
Diversified Revenue Streams: A large installed base of connected devices underpins recurring resupply revenue and remote monitoring workflows. Ownership of Brightree and MatrixCare adds out‑of‑hospital software that complements the core hardware franchise.
UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. We are 340,000 colleagues in two distinct and complementary businesses working to help build a modern, high-performing health system through improved access, affordability, outcomes and experiences. Optum delivers care aided by technology and data,...
UnitedHealth Group's Top Stability & Growth Strengths
Strong Market Position & Advantage: Rankings on the 2026 Fortune 500 and Global 500 reflect industry-leading revenue scale. AM Best identifies the company as the largest public insurer in the U.S./Canada, with Optum Rx among the "Big 3" PBMs.
Diversified Revenue Streams: A vertically integrated model spans UnitedHealthcare and Optum (Health, Insight, Rx), combining insurance, care delivery, pharmacy benefits, and analytics. This breadth supports performance across funding cycles and care settings.
Strong Revenue Growth: Consolidated revenue rose to about $447.6 billion in 2025 from $400.3 billion in 2024, and 2026 has delivered consecutive quarters around $112 billion while full-year earnings guidance was raised.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 20,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology,...
Henry Schein's Top Stability & Growth Strengths
Strong Market Position & Advantage: Regulators, company filings, and independent coverage characterize Henry Schein as a top full‑service dental distributor with global scale and Fortune 500 standing. Its role in an FTC‑recognized oligopoly and breadth across distribution and software reinforce durable competitive advantages.
Resilient & Sustainable Growth: Recent results indicate steady year‑over‑year increases in sales and EPS, and management has reaffirmed guidance for modest top‑line and EBITDA growth. Share repurchases and a multi‑year operating‑income improvement program support a measured compounding profile.
Future-Ready Strategy: The company is investing in higher‑growth technology and value‑added services and pursuing AI‑enabled initiatives alongside a defined multi‑year operating plan. Portfolio moves in software, digital solutions, and specialty offerings are positioned to create switching costs and embed workflows in practices.
Blue Zinc is a technology company in the health industry, specialising in improving, connecting and automating the musculoskeletal and talking therapies arenas. We produce solutions for all parts of the market, from funders to practitioners.
Eakin Healthcare is a family-owned medical device manufacturer based in Northern Ireland. The company specializes in the production and supply of high-quality medical devices and skin protection products across three main therapy areas: Ostomy, Respiratory, and Surgical. With over 50 years of experience, they are dedicated to improving the lives of patients worldwide through innovative solutions and expert care.
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with...
Stryker's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show double-digit annual sales expansion through 2025, with management guiding to continued organic growth into 2026.
Strong Market Position & Advantage: Evidence highlights leadership in orthopedic robotics and top-tier standings among global medtech peers, with notable share in joint replacement and integrated OR technologies.
Diversified Revenue Streams: Multiple segments and recent vascular-focused acquisitions broaden growth drivers and reduce reliance on any single category.
Organon is a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established medicines across a wide array of conditions and diseases. Our mission is to deliver impactful medicines and solutions for a healthier every day. This site is intended for residents of the United States and its territories. You are reminded to protect yourself...
Organon's Top Stability & Growth Strengths
Strong Market Position & Advantage: Organon is repeatedly characterized as a leader in women’s health, with Nexplanon anchoring a dominant position in contraceptive implants and an extended label that reinforces its edge. A broad footprint across 140+ markets and focus on conditions affecting women underpin this positioning.
Healthy Cash Flow: Established brands are described as providing stable cash flows that fund R&D and growth initiatives in women’s health and biosimilars. Despite mixed topline trends, management highlights ongoing cash generation supporting deleveraging and reinvestment.
Strategic Partnerships: Partnerships such as Samsung Bioepis in biosimilars and commercial collaborations with large biopharma companies expand the portfolio and market access. A pipeline supported by multiple alliances is cited as a core pillar of its strategy.
